Wells Fargo & Company »

Mymd Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Mymd Pharmaceuticals (TNFA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $306 167 1.84
2024-03-31 $424 177 2.40

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth Call Option (UNH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wells Fargo & Company

Top funds holding Mymd Pharmaceuticals

Geode Capital Management
Vanguard Group
Virtu Financial
BlackRock
Parallel Advisors
Group One Trading
Morgan Stanley
Wells Fargo & Company
Sandy Spring Bank
Harbor Investment Advisory
Redwood Wealth Management Group
Royal Bank of Canada
Tower Research Capital
ORG Wealth Partners
Arvest Investments

View all funds holding Mymd Pharmaceuticals